TipRanks
Go Ultimate55% OFF

Softmax Co., Ltd. (Japan) (3671) AI Stock Analysis

JP:3671

Softmax Co., Ltd. (Japan)

(TSE/TYO:3671)

Select Model
Rating:75Outperform
Price Target:JPY 312.00â–²(12.64% Upside)
Action:reiterated
Date:08/06/26

The stock's score of 75 reflects strong financial performance and attractive valuation, offset by neutral technical indicators. The company exhibits robust revenue growth, stable profitability, and healthy cash generation, while its P/E and dividend yield indicate undervaluation. Recent margin pressure and increased debt are areas to monitor. Technicals show mixed trends but no strong directional signal.

Positive Factors
Durable ProfitabilityConsistent profitability across multiple years indicates that Softmax has maintained an economically viable healthcare IT operation despite recent weakness. Sustained net and EBIT margins provide an earnings base that can support product investment, customer service, and continued business operations.
Negative Factors
Revenue ContractionThe sharp latest-year revenue decline signals weaker demand or deployment activity and interrupts the company’s preceding growth pattern. If the contraction persists, lower scale would reduce operating leverage, constrain reinvestment, and make recovery in earnings more dependent on renewed customer wins.

Softmax Co., Ltd. (Japan) (3671) vs. iShares MSCI Japan ETF (EWJ)

-30%-20%-10%0%10%20%30%JP:3671-27.33%EWJ+15.87%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
Market Cap
JPY 6.66B
Dividend Yield
3.61%
Average Volume (3M)
28.16K
Price to Earnings (P/E)
12.9
Beta (1Y)
0.53
Revenue Growth
0.37%
EPS Growth
-20.03%
Country
Japan
Employees
230
Sector
General
Sector Strength
55
Industry
Medical - Healthcare Information Services

Softmax Co., Ltd. (Japan) Business Overview & Revenue Model

Company Description

Softmax Co., Ltd handles the complete spectrum of corporate system services, encompassing their development, commercialization, deployment, and ongoing support. A significant portion of their work is dedicated to creating advanced medical information...

How the Company Makes Money

Softmax makes money mainly by selling and supporting healthcare IT systems for medical institutions. Its revenue is typically generated through (1) software/system sales and implementation fees for deploying its healthcare solutions (including config...

Softmax Co., Ltd. (Japan) Financial Statement Overview

Summary

Revenue growth of 27.7% in latest year, stable net margins (8-9%), though gross margin compression indicates rising costs. Balance sheet shows increasing equity (Â¥3.9B) and moderate debt (D/E 0.63). Operating cash flow positive, free cash flow strong. Overall strong financial health with minor concerns.

Income Statement

85Very Positive

Balance Sheet

80Positive

Cash Flow

80Positive
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue6.97B6.93B5.43B5.26B5.05B4.49B
Gross Profit1.86B1.86B1.66B1.55B1.43B1.44B
EBITDA706.65M784.12M702.47M621.88M571.83M612.45M
Net Income517.88M573.46M480.15M452.77M419.39M422.55M
Balance Sheet
Total Assets8.53B9.13B7.54B6.72B6.55B5.76B
Cash, Cash Equivalents and Short-Term Investments2.77B3.12B3.45B2.92B2.85B2.76B
Total Debt2.44B2.48B1.41B1.33B1.35B1.38B
Total Liabilities4.59B5.20B4.02B3.50B3.61B3.14B
Stockholders Equity3.93B3.93B3.52B3.22B2.94B2.62B
Cash Flow
Free Cash Flow0384.89M625.84M215.28M163.96M266.65M
Operating Cash Flow0388.95M663.98M232.54M179.73M284.30M
Investing Cash Flow0-1.17B-92.76M-11.61M-4.75M-1.01M
Financing Cash Flow0883.56M-100.22M-200.04M-144.93M-401.85M

Softmax Co., Ltd. (Japan) Technical Analysis

Technical Analysis SentimentNegative
Last Price277.00

Price Trends

50DMA304.26Negative
100DMA305.40Negative
200DMA319.30Negative

Market Momentum

MACD-8.48Positive
RSI26.80Positive
STOCH8.85Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:3671, the sentiment is Negative. The current price of 277.00 is below the 20-day moving average (MA) of 301.05, below the 50-day MA of 304.26, and below the 200-day MA of 319.30, indicating a bearish trend. The MACD of -8.48 indicates Positive momentum. The RSI at 26.80 is Positive, neither overbought nor oversold. The STOCH value of 8.85 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for JP:3671.

Softmax Co., Ltd. (Japan) Peers Comparison

Overall Rating

UnderperformOutperform
Sector (55)

Financial Indicators

JP:3671 against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
JP:3671JP:367175OutperformJPY 6.66B12.86―3.61%0.37%-20.03%
JP:4483JP:448372OutperformJPY 241.50B34.84―0.49%18.89%11.66%
JP:4480JP:448063NeutralJPY 75.89B39.6912.35%―24.03%34.50%
JP:9341JP:934161NeutralJPY 10.44B16.26―5.13%36.94%-31.50%
Sector *55Neutral$6.65B3.83-15.92%6.20%10.91%7.18%
JP:4438JP:443850NeutralJPY 2.36B-4.42――14.84%30.67%

* General Sector Average

Performance Comparison

-50%0%50%JP:3671JP:4480JP:4438JP:4483JP:9341Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26
JP:3671 and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
JP:3671Softmax Co., Ltd. (Japan)277.00-104.20-27.33%
JP:4480Medley, Inc.2386.00280.0013.30%
JP:4438Welby Inc.276.00-13.00-4.50%
JP:4483JMDC Inc.3690.00-1186.28-24.33%
JP:9341GENOVA Inc.585.0033.906.15%
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Aug 06, 2026